Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1993-10-25
1996-04-30
Datlow, Philip I.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514292, 544101, 546 86, 546 87, C07D47104, C07D49804, A61K 31435, A61K 31535
Patent
active
055125662
ABSTRACT:
Compounds represented by the general formula I: ##STR1## are disclosed as useful in treating diseases of the central nervous system.
REFERENCES:
patent: 3755584 (1973-08-01), Plotnikoff
Cecil Textbook of Medicine, 19th ed. (1992), Wyngaarden, M.D. editor, pp. 2075-2078.
Synthesis of 2,3,4,4a,5,6--Hexahydro--1(H)--Pyrazino 1,2--a!Quinoline & Its 3--Substituted Derivatives; (Miss) V. Aruna Rao, et al.; Communication No. 1389, pp. 833-835, Ind. J. Chem (1969).
Berend Olivier, et al.; Serenics; DN&P 3(5), Jun. 1990, pp. 261-271.
D. S. Charney, M.D., et al.; Serotonin--Specific Drugs For Anxiety And Depressive Disorders, pp. 437-446, Annu. Rev. Med. 41 (1990).
Naresh Kumar, et al., Agents Acting On CNS: Part XXVIII-Synthesis Of 3--Substituted 2,3,4,4a,5,6--Hexahydro--1(H)--Pyrazino 1,2--a!Quinoxaline Disorders, pp. 244-245, Indian Journal of Chemistry, vol. 17B, Mar. 1979.
S. P. Gupta, et al., Compounds Acting On CNC: Part XXII--Synthesis of 2,3,4,4a,5,6--Hexahydro--1(H)--Pyrazineo 2,1--c!--1,4--Benzoxazines, Indian Journal of Chemistry, vol. 13, May 1975, pp. 462-467.
James S. New, Ph.D., The Discovery And Development Of Buspirone: A New Approach To The Treatment Of Anxiety, Medicinal Research Reviews, vol. 10, No. 3, 283-326 (1990).
Joel R. Huff, et al., Bioactive Conformation Of 1--Arylipiperazines At Central Serotonin Receptors, J. Med. Chem. 1985, 28, 945-948.
V. Aruna Rao, et al. Agents Acting On The Central Nervous System. XIII. 2,3,4,4A,5,6--Hexahydro--1(H)--Pyrazino 1,2--A!Quinolines. A New Class Of Hypotensive Agents, Journal of Medicinal Chemistry, 1970, vol. 13, No. 3,pp. 516-522.
Micheal D. Ennis, et al., Novel Indolodioxanes With Antihypertensive Effects: Potent Ligands For The 5--HT.sub.1 A Receptor, J. Med. Chem. 35 (1992), pp. 3058-3066.
Michael G. N. Russell, et al., Benz f!Isoquinoline Analogues As High-Affinity .sigma. Ligands, Journal of Medicinal Chemistry, 1992, vol. 35, No. 11, pp. 2025-2033.
Baxter Ellen W.
Reitz Allen B.
Datlow Philip I.
Ortho Pharmaceutical Corporation
Palo Ralph R.
LandOfFree
Tricyclic compounds having affinity for the 5-HT1A receptor does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tricyclic compounds having affinity for the 5-HT1A receptor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tricyclic compounds having affinity for the 5-HT1A receptor will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-628873